Literature DB >> 11012749

Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection.

M S Hossain1, H Takimoto, T Ninomiya, H Yoshida, K Kishihara, G Matsuzaki, G Kimura, K Nomoto.   

Abstract

In this study, we have investigated that after the intraperitoneal infection with murine cytomegalovirus (MCMV), the CD3+ CD4- CD8-(double negative; DN) T-cell receptor (TCR)alphabeta+ T cells increased in peritoneal cavity, liver and spleen in both resistant C57BL/6 and susceptible BALB/c mice. The total cellular population of these cells showed peak levels around day 5 after infection in all the three investigated organs and the following phenotypical and functional characteristics emerged. The peritoneal DN TCRalphabeta+ T cells expressed highly skewed TCRVbeta8 on day 5 after infection compared with the uninfected mice, but those in spleen and liver showed moderate and low skewed TCRVbeta8, respectively. The percentages of NK1.1+ DN TCRalphabeta+ T cells gradually decreased as did modulation of some of their activation markers consistent with an activated cell phenotype. The peritoneal DN TCRalphabeta+ T cells on day 5 after infection expressed the genes of interferon-gamma (IFN-gamma), tumour necrosis factor-alpha, Eta-1 (early T-cell activation-1) and MCP-1 (monocyte chemoattractant protein 1) but lacked expression of interleukin-4 (IL-4). After in vitro stimulation with phorbol 12-myristate 13-acetate and calcium ionophore in the presence of Brefeldin A, higher frequencies of intracellular IFN-gamma+ DN TCRalphabeta+ T cells were detected in all three investigated organs of infected mice compared with those of uninfected mice. Stimulation of peritoneal DN TCRalphabeta+ T cells with plate-bound anti-TCRbeta monoclonal antibodies showed proliferation and also produced IFN-gamma but not IL-4. These results suggest that DN TCRalphabeta+ T cells were activated and may have an antiviral effect through producing IFN-gamma and some macrophage-activating factors during an early phase of MCMV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012749      PMCID: PMC2327051          DOI: 10.1046/j.1365-2567.2000.00052.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4.

Authors:  A Zlotnik; D I Godfrey; M Fischer; T Suda
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

Review 2.  Double-negative (CD4-CD8-), TCR alpha beta-expressing, peripheral T cells.

Authors:  J Reimann
Journal:  Scand J Immunol       Date:  1991-12       Impact factor: 3.487

3.  Characterization of alpha beta+ CD4- CD8- CTL lines isolated from mixed lymphocyte cultures of adult mouse spleen cells.

Authors:  M A Skinner; S R Sambhara; P Benveniste; R G Miller
Journal:  Cell Immunol       Date:  1992-02       Impact factor: 4.868

4.  Interferon: a cytotoxic T lymphocyte differentiation signal.

Authors:  L K Chen; B Tourvieille; G F Burns; F H Bach; D Mathieu-Mahul; M Sasportes; A Bensussan
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

5.  Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.

Authors:  K Kikly; G Dennert
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

6.  Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes.

Authors:  J E Grundy; J Trapman; J E Allan; G R Shellam; C J Melief
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity.

Authors:  V Palathumpat; S Dejbakhsh-Jones; B Holm; H Wang; O Liang; S Strober
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

8.  Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.

Authors:  P Lucin; I Pavić; B Polić; S Jonjić; U H Koszinowski
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria.

Authors:  T Abo; T Ohteki; S Seki; N Koyamada; Y Yoshikai; T Masuda; H Rikiishi; K Kumagai
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

10.  Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes.

Authors:  R C Budd; G C Miescher; R C Howe; R K Lees; C Bron; H R MacDonald
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Double-negative regulatory T cells: non-conventional regulators.

Authors:  Christopher W Thomson; Boris P-L Lee; Li Zhang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.

Authors:  Liguo Niu; Simona Strahotin; Becker Hewes; Benyue Zhang; Yuanyuan Zhang; David Archer; Trent Spencer; Dirck Dillehay; Byoung Kwon; Lieping Chen; Anthony T Vella; Robert S Mittler
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Authors:  Mohammad S Hossain; David L Jaye; Brian P Pollack; Alton B Farris; Malefa L Tselanyane; Ebenezer David; John D Roback; Andrew T Gewirtz; Edmund K Waller
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

4.  Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.

Authors:  Kamiya Mehla; Jarrod Tremayne; James A Grunkemeyer; Kelly A O'Connell; Maria M Steele; Thomas C Caffrey; Xinyi Zhu; Fang Yu; Pankaj K Singh; Birgit C Schultes; Ragupathy Madiyalakan; Christopher F Nicodemus; Michael A Hollingsworth
Journal:  Cancer Immunol Immunother       Date:  2017-12-04       Impact factor: 6.968

5.  The checkpoint for agonist selection precedes conventional selection in human thymus.

Authors:  Greet Verstichel; David Vermijlen; Liesbet Martens; Glenn Goetgeluk; Margreet Brouwer; Nicolas Thiault; Yasmine Van Caeneghem; Stijn De Munter; Karin Weening; Sarah Bonte; Georges Leclercq; Tom Taghon; Tessa Kerre; Yvan Saeys; Jo Van Dorpe; Hilde Cheroutre; Bart Vandekerckhove
Journal:  Sci Immunol       Date:  2017-02-24

6.  Chronic GvHD decreases antiviral immune responses in allogeneic BMT.

Authors:  Mohammad S Hossain; John D Roback; Brian P Pollack; David L Jaye; Amelia Langston; Edmund K Waller
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

7.  CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.

Authors:  Siobhán C Cowley; Elizabeth Hamilton; Jeffrey A Frelinger; Jie Su; James Forman; Karen L Elkins
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

8.  Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction.

Authors:  Jessica R Doll; Kasper Hoebe; Richard L Thompson; Nancy M Sawtell
Journal:  PLoS Pathog       Date:  2020-03-05       Impact factor: 6.823

9.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.